These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 31850928

  • 1. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fung BM, Tabibian JH.
    Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
    [Abstract] [Full Text] [Related]

  • 2. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM, Tabibian JH.
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME.
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [Abstract] [Full Text] [Related]

  • 5. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
    Saca D, Flamm SL.
    Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
    [Abstract] [Full Text] [Related]

  • 6. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN, Gores GJ.
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [Abstract] [Full Text] [Related]

  • 7. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H, Schramm C.
    Dig Dis; 2013 Feb; 31(1):118-25. PubMed ID: 23797133
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidemiology of cholangiocarcinoma.
    Bergquist A, von Seth E.
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
    Grimsrud MM, Folseraas T.
    Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
    [Abstract] [Full Text] [Related]

  • 13. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C, Friis-Liby I, Rorsman F, Said K, Warnqvist A, Cornillet M, Kechagias S, Nyhlin N, Werner M, Janczewska I, Hagström T, Nilsson E, Bergquist A.
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S, Gores GJ.
    Digestion; 2014 Mar; 89(3):216-24. PubMed ID: 24860985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
    Ilyas SI, Eaton JE, Gores GJ.
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2152-65. PubMed ID: 26051390
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.